Progesterone in the treatment of acute traumatic brain injury: A clinical perspective and update

Neuroscience

Volumn 191, Issue , 2011, Pages 101-106

  Stein, D G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Neuroprotection; Neurosteroid; Pharmacotherapy; Progesterone; Traumatic brain injury

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; PLACEBO; PROGESTERONE;

BRAIN CORTEX; BRAIN DAMAGE; CELL PROLIFERATION; CLINICAL STUDY; COGNITION; CONTINUOUS INFUSION; DISEASE DURATION; DRUG DESIGN; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FUNCTIONAL STATUS; GLASGOW COMA SCALE; HUMAN; LOW DRUG DOSE; MORTALITY; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROPROTECTIVE AGENTS; PROGESTERONE;

EID: 80052263533     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.04.013     Document Type: Review

References (56)

1. Alderson P., Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev 2000, 2000. CD000196.
2. Baulieu E.E. Neurosteroids: a new function in the brain. Biol Cell 1991, 71:3-10.
3. Baulieu E.E., Robel P. Neurosteroids: a new brain function?. J Steroid Biochem Mol Biol 1990, 37:395-403.
4. Baulieu E.E., Robel P., Schumacher M. Neurosteroids: beginning of the story. Int Rev Neurobiol 2001, 46:1-32.
5. Bethea C.L. MPA: medroxy-progesterone acetate contributes to much poor advice for women. Endocrinology 2011, 152:343-345.
6. Centers for Disease Control and Prevention, Accessed April 14, 2011. http://www.cdc.gov/traumaticbraininjury/statistics.html.
7. Chen G., Shi J., Ding Y., Yin H., Hang C. Progesterone prevents traumatic brain injury-induced intestinal nuclear factor kappa B activation and proinflammatory cytokines expression in male rats. Mediators Inflamm 2007, 2007:93431.
8. Ciriza I., Carrero P., Frye C.A., Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J Neurobiol 2006, 66:916-928.
9. Clark W.M., Wechsler L.R., Sabounjian L.A., Schwiderski U.E. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001, 57:1595-1602.
10. Cutler S.M., Pettus E.H., Hoffman S.W., Stein D.G. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 2005, 195:423-429.
11. De Nicola A.F., Labombarda F., Deniselle M.C., Gonzalez S.L., Garay L., Meyer M., Gargiulo G., Guennoun R., Schumacher M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol 2009, 30:173-187.
12. Doppenberg E.M., Choi S.C., Bullock R. Clinical trials in traumatic brain injury: lessons for the future. J Neurosurg Anesthesiol 2004, 16:87-94.
13. Edwards P., Arango M., Balica L., Cottingham R., El-Sayed H., Farrell B., Fernandes J., Gogichaisvili T., Golden N., Hartzenberg B., Husain M., Ulloa M.I., Jerbi Z., Khamis H., Komolafe E., Laloe V., Lomas G., Ludwig S., Mazairac G., Munoz Sanchez, Mde L., Nasi L., Olldashi F., Plunkett P., Roberts I., Sandercock P., Shakur H., Soler C., Stocker R., Svoboda P., Trenkler S., Venkataramana N.K., Wasserberg J., Yates D., Yutthakasemsunt S. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005, 365:1957-1959.
14. Fee D.B., Swartz K.R., Joy K.M., Roberts K.N., Scheff N.N., Scheff S.W. Effects of progesterone on experimental spinal cord injury. Brain Res 2007, 1137:146-152.
15. Gibson C.L., Gray L.J., Bath P.M., Murphy S.P. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008, 131:318-328.
16. Gilmer L.K., Roberts K.N., Scheff S.W. Efficacy of progesterone following a moderate unilateral cortical contusion injury. J Neurotrauma 2008, 25:593-602.
17. Glantz L., Avramovich A., Trembovler V., Gurvitz V., Kohen R., Eidelman L.A., Shohami E. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp Neurol 2005, 192:117-124.
18. Gomes J.A., Stevens R.D., Lewin J.J., Mirski M.A., Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Crit Care Med 2005, 33:1214-1224.
19. Grasso G., Graziano F., Sfacteria A., Carletti F., Meli F., Maugeri R., Passalacqua M., Certo F., Fazio M., Buemi M., Iacopino D.G. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery 2009, 65:763-769. discussion 769-770.
20. Hang C.H., Shi J.X., Li J.S., Li W.Q., Wu W. Expressions of intestinal NF-kappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats. J Surg Res 2005, 123:188-193.
21. Hang C.H., Shi J.X., Sun B.W., Li J.S. Apoptosis and functional changes of dipeptide transporter (PepT1) in the rat small intestine after traumatic brain injury. J Surg Res 2007, 137:53-60.
22. Hatton J., Rosbolt B., Empey P., Kryscio R., Young B. Dosing and safety of cyclosporine in patients with severe brain injury. J Neurosurg 2008, 109:699-707.
23. Hirst J.J., Walker D.W., Yawno T., Palliser H.K. Stress in pregnancy: a role for neuroactive steroids in protecting the fetal and neonatal brain. Dev Neurosci 2009, 31:363-377.
24. Ippolito C.J. Battlefield TBI: blast and aftermath. Psychiatric Times 7 August 1, 2007, Accessed April 1, 2011. http://www.psychiatrictimes.com/display/article/10168/5691.
25. Irwin R.W., Yao J., Ahmed S.S., Hamilton R.T., Cadenas E., Brinton R.D. Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function. Endocrinology 2011, 152:556-567.
26. Jodhka P.K., Kaur P., Underwood W., Lydon J.P., Singh M. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology 2009, 150:3162-3168.
27. Kaur P., Jodhka P.K., Underwood W.A., Bowles C.A., de Fiebre N.C., de Fiebre C.M., Singh M. Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res 2007, 85:2441-2449.
28. Kelleher M.A., Palliser H.K., Walker D.W., Hirst J.J. Sex-dependent effect of a low neurosteroid environment and intrauterine growth restriction on foetal guinea pig brain development. J Endocrinol 2011, 208:301-309.
29. Labombarda F., Gonzalez S.L., Lima A., Roig P., Guennoun R., Schumacher M., de Nicola A.F. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 2009, 57:884-897.
30. Leitner H. Influence of neurosteroids on the pathogenesis of multiple sclerosis. Med Hypotheses 2010, 75:229-234.
31. Liu L., Zhao L., She H., Chen S., Wang J.M., Wong C., McClure K., Sitruk-Ware R., Brinton R.D. Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology 2010, 151:5782-5794.
32. Loane D.J., Faden A.I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010, 31:596-604.
33. Mammis A., McIntosh T.K., Maniker A.H. Erythropoietin as a neuroprotective agent in traumatic brain injury review. Surg Neurol 2009, 71:527-531. discussion 531.
34. Nilsen J., Morales A., Brinton R.D. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol Endocrinol 2006, 22:355-361.
35. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006, 176:6523-6531.
36. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., Cottingham R., Svoboda P., Brayley N., Mazairac G., Laloe V., Munoz-Sanchez A., Arango M., Hartzenberg B., Khamis H., Yutthakasemsunt S., Komolafe E., Olldashi F., Yadav Y., Murillo-Cabezas F., Shakur H., Edwards P. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
37. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Neurotherapy 2009, Vol. 175:219-237. Elsevier, New York. J. Verhaagen (Ed.).
38. Schneier A.J., Shields B.J., Hostetler S.G., Xiang H., Smith G.A. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics 2006, 118:483-492.
39. Schumacher M., Guennoun R., Stein D.G., De Nicola A.F. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007, 116:77-106.
40. Schumacher M., Robel P., Baulieu E.E. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 1996, 18:6-21.
41. Schumacher M., Sitruk-Ware R., De Nicola A.F. Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol 2008, 8:740-746.
42. Shohami E., Gati I., Beit-Yannai E., Trembovler V., Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma 1999, 16:365-376.
43. Stein D.G., Hoffman S.W. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 2003, 6:13-22.
44. Stein D.G., Hurn P.D. Effects of sex steroids on damaged neural systems. Hormones, brain and behavior 2009, Vol. 4:2223-2258. Elsevier, Oxford. D.W.D. Pfaff (Ed.).
45. Temkin N.R., Anderson G.D., Winn H.R., Ellenbogen R.G., Britz G.W., Schuster J., Lucas T., Newell D.W., Mansfield P.N., Machamer J.E., Barber J., Dikmen S.S. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 2007, 6:29-38.
46. Toung T.J., Chen T.Y., Littleton-Kearney M.T., Hurn P.D., Murphy S.J. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 2004, 24:1160-1166.
47. UC Davis to study drug therapy to minimize death and disability from traumatic brain injury University of California-Davis, [press release]. http://ucdmc.ucdavis.edu/welcome.features/20100203_brain_injury/index.html.
48. Utagawa A., Truettner J.S., Dietrich W.D., Bramlett H.M. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol 2008, 211:283-291.
49. Vilalta A., Sahuquillo J., Rosell A., Poca M.A., Riveiro M., Montaner J. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Intensive Care Med 2008, 34:1384-1392.
50. Vink R., Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 2009, 6:28-42.
51. Vink R., Van Den Heuvel C. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin Investig Drugs 2004, 13:1263-1274.
52. Watson N.F., Barber J.K., Doherty M.J., Miller J.W., Temkin N.R. Does glucocorticoid administration prevent late seizures after head injury?. Epilepsia 2004, 45:690-694.
53. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007, 49:391-402.
54. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008, 12:R61.
55. Xiong Y., Mahmood A., Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs 2009, 14:67-84.
56. Zhou M.L., Zhu L., Wang J., Hang C.H., Shi J.X. The inflammation in the gut after experimental subarachnoid hemorrhage. J Surg Res 2007, 137:103-108.